Showing 71-80 of 1741 results for "".
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn1008_10-pdf/30986/Choosing Between Short- and Long-Acting Opioids in Chronic Pain ManagementIn the realm of chronic pain management, selecting the appropriate opioid analgesic—whether short-acting or long-acting—remains a nuanced decision due to limited comparative data. Charles Argoff, MD, in his recent article for
Neurology Q&A: What Neurologists Should Know About Headache Patients and Complimentary Medicine
https://practicalneurology.com/diseases-diagnoses/headache-pain/neurology-qa-what-neurologists-should-know-about-headache-patients-and-complimentary-medicine/30804/Those who suffer from headaches may be more likely to use CAM than others are. Here's what research shows.A Q&A with Rebecca E. Wells, MD, MPHConcussion and Epilepsy: What is the Link?
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/concussion-and-epilepsy-what-is-the-link/30769/Individuals who suffer a traumatic brain injury are at increased risk for developing seizures. Here's an update to the current evidence and implications for monitoring.Insights from G. Alexander Hishaw, MDSevere Calcineurin Inhibitor-Induced Parkinsonism After Kidney Transplantation
https://practicalneurology.com/diseases-diagnoses/movement-disorders/severe-calcineurin-inhibitor-induced-parkinsonism-after-kidney-transplantation/32161/A case of debilitating parkinsonism induced by tacrolimus use.- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1108Epilepsy-pdf/30972/New Insights into Seizure Recurrence Risk and Epilepsy Management in WomenIn a recent issue of *Practical Neurology* (November 2008), significant findings were presented regarding the recurrence risk of seizures in children following a first afebrile, unprovoked seizure and the specialized managemen
Myasthenia Gravis Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis-treatment-1/31690/There are both disease-modifying and symptom-reducing treatments available and emerging treatment possibilities.Treating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processMovement Disorders in Antiphospholipid Syndrome & Systemic Lupus Erythematosus
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-in-antiphospholipid-syndrome-systemic-lupus-erythematosus/31706/Several movement disorders are seen with APS and SLE, most commonly chorea.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31204/Summary of Recent Advances and Findings in NeurologyThe 2007 American Stroke Association’s International Stroke Conference in San Francisco highlighted critical barriers in stroke management and innovative therapeutic advancements. A significant finding revealed that approximately 50% of individuals
MS Minute: The COVID-19 Vaccine & Vaccine Readiness in MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-the-covid-19-vaccine-vaccine-readiness-in-ms/31748/Evidence suggests all people with multiple sclerosis, including those on any class of disease-modifying treatment, can and should be vaccinated against COVID-19.